Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
50
IIIV Quote, Financials, Valuation and Earnings
Last price:
$24.02
Seasonality move
:
0.27%
Day range:
$23.01 - $24.07
52-week range:
$18.75 - $29.80
Dividend yield:
0%
P/E ratio:
5.35x
P/S ratio:
2.31x
P/B ratio:
1.50x
Volume:
175.8K
Avg. volume:
215K
1-year change:
9.16%
Market cap:
$562.6M
Revenue:
$229.9M
EPS (TTM):
$4.49
i3 Verticals Number of Institutional Trades
i3 Verticals Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$567.9M
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$960.2M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
i3 Verticals Institutional Ownership
-
What Percentage Of IIIV Is Owned by Institutions?
-- of IIIV is owned by institutions.
-
How Many Institutions Own IIIV Shares?
i3 Verticals stock is owned by 336 institutional shareholders at this time.
-
Have Institutions Been Buying IIIV Stock?
Yes, institutions have bought 15M shares of IIIV in the last quarter.
-
Have Institutions Been Selling IIIV Stock?
Yes, institutions have sold 24.8M shares of IIIV over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
